Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Smartwatches gather vast amounts of data about our physiology. Now their technology is being harnessed like never before.

Pharma Two B Ltd. ("Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A new study shows that a common glaucoma drug cleared tau build-up and reduced signs of neurodegenerative disease in zebrafish and mice.

Researchers have developed an AI system that predicts chemical compounds capable of targeting two proteins simultaneously, ...

BioSpace has been compiling a list of the most innovative and exciting biotechs for a decade. Here we take a look back at ...

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...

nonsteroidal antiinflammatory drugs, opioids, Parkinson's disease medications, and overactive bladder medications. Univariate logistic regression models were developed for each risk factor to ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...